Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 Jan;37(1):13–20. doi: 10.1111/j.1365-2125.1994.tb04232.x

Examination of some factors responsible for a food-induced increase in absorption of atovaquone.

P E Rolan 1, A J Mercer 1, B C Weatherley 1, T Holdich 1, H Meire 1, R W Peck 1, G Ridout 1, J Posner 1
PMCID: PMC1364703  PMID: 8148213

Abstract

1. Atovaquone is a potent antiprotozoal slowly and irregularly absorbed after administration as tablets to fasting volunteers. A series of studies was performed to investigate the effects of food, bile and formulation on atovaquone absorption. 2. In 18 healthy male volunteers, a high-fat breakfast administered 45 min before 500 mg atovaquone as tablets increased AUC by 3.3-fold (95% CI 2.8-4.0) and Cmax 5.3-fold (4.3-6.6) compared with fasting. 3. The absorption of atovaquone from tablets was examined in 12 healthy male volunteers after an overnight fast, following toast alone, toast with 28 g butter (LOFAT), or toast with 56 g butter (HIFAT). Compared with absorption when fasted, toast had no significant effect but LOFAT increased AUC 3.0-fold (2.1-4.2) and Cmax 3.9-fold (2.6-5.8). HIFAT increased AUC 3.9-fold (2.7-5.5) and Cmax 5.6-fold (3.8-8.4). 4. The absorption of atovaquone was examined in nine healthy fasting male volunteers from tablets, an aqueous suspension, and an oily solution/suspension in miglyol (fractionated coconut oil). Compared with tablets, AUC following the aqueous suspension was increased 1.7-fold (1.0-2.7) and Cmax 2.4-fold (1.7-3.5). Following miglyol, AUC was increased to the same extent but Cmax was only increased 1.8-fold (1.2-2.6). 5. Atovaquone absorption was examined in eight healthy fasting male volunteers following an i.v. infusion of cholecystokinin octapeptide (CCK-OP) which decreased gallbladder volume by 82% (73%-90%) on occasion 1 or saline on occasion 2. AUC(0,12) was increased following CCK-OP by 1.6-fold (1.1-2.4) and Cmax by 1.5-fold (0.98-2.4).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aukee S., Venho V. M., Jussila J., Karjalainen P. Drug absorption in patients with T-tube after cholecystectomy. Ann Clin Res. 1975 Feb;7(1):42–46. [PubMed] [Google Scholar]
  2. Badley B. W., Murphy G. M., Bouchier I. A. Intraluminal bile-salt deficiency in the pathogenesis of steatorrhoea. Lancet. 1969 Aug 23;2(7617):400–402. doi: 10.1016/s0140-6736(69)90111-1. [DOI] [PubMed] [Google Scholar]
  3. Bates T. R., Sequeria J. A. Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans. J Pharm Sci. 1975 May;64(5):793–797. doi: 10.1002/jps.2600640513. [DOI] [PubMed] [Google Scholar]
  4. Chakrabarti S., Belpaire F. M. Biovailability of phenytoin in lipid containing dosage forms in rats. J Pharm Pharmacol. 1978 May;30(5):330–331. doi: 10.1111/j.2042-7158.1978.tb13247.x. [DOI] [PubMed] [Google Scholar]
  5. Falloon J., Kovacs J., Hughes W., O'Neill D., Polis M., Davey R. T., Jr, Rogers M., LaFon S., Feuerstein I., Lancaster D. A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1991 Nov 28;325(22):1534–1538. doi: 10.1056/NEJM199111283252202. [DOI] [PubMed] [Google Scholar]
  6. Forgacs I. C., Maisey M. N., Murphy G. M., Dowling R. H. Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology. 1984 Aug;87(2):299–307. [PubMed] [Google Scholar]
  7. Forsgren L. Studies on the intestinal absorption of labelled fat-soluble vitamins (A, D, E, and K) via the thoracic-duct lymph in the absence of bile in man. Acta Chir Scand Suppl. 1969;399:1–29. [PubMed] [Google Scholar]
  8. HOFMANN A. F. THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS. Biochem J. 1963 Oct;89:57–68. doi: 10.1042/bj0890057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hammond D. J., Burchell J. R., Pudney M. Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol. 1985 Jan;14(1):97–109. doi: 10.1016/0166-6851(85)90109-4. [DOI] [PubMed] [Google Scholar]
  10. Hughes W. T., Gray V. L., Gutteridge W. E., Latter V. S., Pudney M. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1990 Feb;34(2):225–228. doi: 10.1128/aac.34.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes W. T., Kennedy W., Shenep J. L., Flynn P. M., Hetherington S. V., Fullen G., Lancaster D. J., Stein D. S., Palte S., Rosenbaum D. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. J Infect Dis. 1991 Apr;163(4):843–848. doi: 10.1093/infdis/163.4.843. [DOI] [PubMed] [Google Scholar]
  12. Hughes W., Leoung G., Kramer F., Bozzette S. A., Safrin S., Frame P., Clumeck N., Masur H., Lancaster D., Chan C. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med. 1993 May 27;328(21):1521–1527. doi: 10.1056/NEJM199305273282103. [DOI] [PubMed] [Google Scholar]
  13. Huskinson-Mark J., Araujo F. G., Remington J. S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis. 1991 Jul;164(1):170–171. doi: 10.1093/infdis/164.1.170. [DOI] [PubMed] [Google Scholar]
  14. Kabasakalian P., Katz M., Rosenkrantz B., Townley E. Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data. J Pharm Sci. 1970 May;59(5):595–600. doi: 10.1002/jps.2600590504. [DOI] [PubMed] [Google Scholar]
  15. Mehta M. U., Venkataramanan R., Burckart G. J., Ptachcinski R. J., Delamos B., Stachak S., Van Thiel D. H., Iwatsuki S., Starzl T. E. Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol. 1988 May;25(5):579–584. doi: 10.1111/j.1365-2125.1988.tb03348.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Milton K. A., Edwards G., Ward S. A., Orme M. L., Breckenridge A. M. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol. 1989 Jul;28(1):71–77. doi: 10.1111/j.1365-2125.1989.tb03507.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Palframan A., Meire H. B. Real-time ultrasound. A new method for studying gall-bladder kinetics. Br J Radiol. 1979 Oct;52(622):801–803. doi: 10.1259/0007-1285-52-622-801. [DOI] [PubMed] [Google Scholar]
  18. Palin K. J., Wilson C. G., Davis S. S., Phillips A. J. The effect of oils on the lymphatic absorption of DDT. J Pharm Pharmacol. 1982 Nov;34(11):707–710. doi: 10.1111/j.2042-7158.1982.tb06204.x. [DOI] [PubMed] [Google Scholar]
  19. Traber M. G., Ingold K. U., Burton G. W., Kayden H. J. Absorption and transport of deuterium-substituted 2R,4'R,8'R-alpha-tocopherol in human lipoproteins. Lipids. 1988 Aug;23(8):791–797. doi: 10.1007/BF02536223. [DOI] [PubMed] [Google Scholar]
  20. Welling P. G. Effects of food on drug absorption. Pharmacol Ther. 1989;43(3):425–441. doi: 10.1016/0163-7258(89)90019-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES